Scholar Rock Holding Corporation (SRRK) vs Travere Therapeutics, Inc. (TVTX)
A side-by-side comparison of Scholar Rock Holding Corporation and Travere Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SRRK
Scholar Rock Holding Corporation
$42.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TVTX
Travere Therapeutics, Inc.
$55.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SRRK vs TVTX
growth of $100 · dividends reinvested · last 8ySRRK +180.0% (+13.7%/yr)TVTX +102.8% (+9.2%/yr)SRRK compounded faster over this window
SRRK TVTX
SRRK vs TVTX: by the numbers
- •TVTX is the larger company ($5.21B vs $5.09B market cap).
- •Both run net losses; SRRK's is the smaller (0.00% vs -7.35% net margin).
Metrics side by side
Valuation
| Metric | SRRK | TVTX |
|---|---|---|
| P/S ratio | N/A | 8.80 |
| P/B ratio | 20.04 | 212.29 |
| EV / EBITDA | N/A | 248.98 |
| FCF yield | N/A | 0.99% |
Profitability
| Metric | SRRK | TVTX |
|---|---|---|
| Gross margin | 0.00% | 94.41% |
| Operating margin | 0.00% | -6.84% |
| Net margin | 0.00% | -7.35% |
| ROE | -161.00% | -177.24% |
| ROIC | -90.04% | -6.19% |
Growth (annualized)
| Metric | SRRK | TVTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 23.71% |
| Total return CAGR (5Y) | 8.20% | 17.83% |
Frequently asked
- How have SRRK and TVTX total returns compared?
- Over the past 5 years, SRRK delivered 8.20% and TVTX delivered 17.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Scholar Rock ROETravere Therapeutics ROEScholar Rock operating marginTravere Therapeutics operating marginScholar Rock revenue growthTravere Therapeutics revenue growthScholar Rock free cash flowTravere Therapeutics free cash flow
Scholar Rock & Travere Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.